Yıl: 2016 Cilt: 16 Sayı: 2 Sayfa Aralığı: 76 - 83 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus

Öz:
Objective: High altitude and hypoxic preconditioning have cardioprotective effects by increasing coronary vascularity, reducing post-ischemic injury, and improving cardiac function. Our purpose was to examine if intermittent hypoxia treatment has any restoring effects related to the possible role of the HIF-1/VEGF pathway on diabetic cardiomyopathy.Methods: Wistar Albino male rats (n=34) were divided into four groups: control (C), intermittent hypoxia (IH), diabetes mellitus (DM), and diabetes mellitus plus intermittent hypoxia (DM+IH). Following a streptozotocin (STZ) injection (50 mg/kg, i.p.), blood glucose levels of 250 mg/dL and above were considered as DM. IH and DM+IH groups were exposed to hypoxia 6 h/day for 42 days at a pressure corresponding to 3000 m altitude. Twenty-four hours after the IH protocol, hearts were excised. Hematoxylin and eosin-stained apical parts of the left ventricles were evaluated. Hypoxia inducible factor-1 (HIF-1), vascular endothelial growth factor 164 (VEGF164), and VEGF188 polymerase chain reaction products were run in agarose gel electrophoresis. Band density analysis of UV camera images was performed using Image J. The data were compared by one-way ANOVA, repeated measures two-way ANOVA, and the Kruskal-Wallis test.Results: The percent weight change was lower in the DM group than in the controls (p=0.004). The tissue injury was the highest in the DM group and the least in the IH group. Diabetes decreased, whereas the IH treatment increased the vascularity. A decrease was observed in the VEGF188 mRNA levels in the DM+IH group compared with the C group, but there were no difference in HIF-1? and VEGF164 mRNA levels between the groups.Conclusion: The IH treatment restored the diabetic effects on the heart by reducing tissue injury and increasing the capillarity without transcriptional changes in HIF-1/VEGF correspondingly.
Anahtar Kelime:

Konular: Kalp ve Kalp Damar Sistemi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
0
0
0
  • Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epi- demiological studies with 370 country-years and 2o7 million par- ticipants. Lancet 2011; 378: 31-40.
  • Pappachan JM, Varughese GI, Sriraman R, Arunagirinathan G. Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management. World J Diabetes 2013; 4: 177-89.
  • Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007; 115: 3213-23.
  • Falcao-Pires I, Leite-Moreira AF. Diabetic cardiomyopathy: Understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev 2012; 17: 325-44.
  • Hayat SA, Patel B, Khattar RJ, Malik RA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clinical Science 2004; 107: 539-57.
  • Bertuglia S. Intermittent hypoxia modulates nitric oxide-dependent vasodilation and capillary perfusion during ischemia-reperfusion- induced damage. Am J Physiol Heart Circ Physiol 2008; 294: H1914-22.
  • Xi L, Tekin D, Gürsoy E, Salloum F, Levasseur JE, Kukreja RC. Evidence that NOS2 acts as a trigger and mediator of late precon- ditioning induced by acute systemic hypoxia. Am J Physiol Heart Circ Physiol 2002; 283: H5-12.
  • Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003; 108: 79-85.
  • Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler AA. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ Res 2006; 98: 133-40.
  • Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler AA. Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury. J Cardiovasc Pharmacol 2008; 51: 178-87.
  • Tekin D, Dursun AD, Xi L. Hypoxia inducible factor 1 (HIF-1) and cardioprotection. Acta Pharmacologica Sinica 2010; 31: 1085- 94.
  • Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascu- lar endothelial growth factor gene expression in endothelial cells. Identification of a 5'enhancer. Circ Res 1995; 77: 638-43.
  • Shinohara K, Shinohara T, Mochizuki N, Mochizuki Y, Sawa H, Kohya T, et al. Expression of vascular endothelial growth factor in human myocardial infarction. Heart Vessels 1996; 11: 113-22.
  • Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000; 342: 626-33.
  • Tekin D, Dursun AD, Baştuğ M, Karaorman G, Fıçıcılar H. The effects of acute and intermittent hypoxia on the expressions of HIF-1? and VEGF in the left and right ventricles of the rabbit heart. Anatol J Cardiol 2011; 11: 379-85.
  • Ning XH, Chen SH, Buroker NE, Xu CS, Li FR, Li SP, et al. Short-cycle hypoxia in the intact heart: hypoxia-inducible factor 1? signaling and the relationship to injury threshold. Am J Physiol Heart Circ Physiol 2007; 292: H333-41.
  • Birot OJ, Peinnequin A, Simler N, van Cuyck-Gandre H, Hamel R, Bigard XA. Vascular endothelial growth factor expression in heart of rats exposed to hypobaric hypoxia: differential response between mRNA and protein. J Cell Physiol 2004; 200: 107-15.
  • Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, et al. Decreased cardiac expression of vascular endothelial growth fac- tor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002; 105: 373-9.
  • Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, Gwon HC, et al. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 2005; 111: 2073-85.
  • Eisenbarth GS. Update in type 1 diabetes. J Clin Endocrinol Metab 2007; 92: 2403-7.
  • Joffe II, Travers KE, Perreault-Micale CL, Hampton T. Abnormal cardiac function in the streptozotocin-induced, non-insulin-depen- dent diabetic rat. J Am Coll Cardiol 1999; 34: 2111-9.
  • Available from: http://www.avs.org/AVS/files/c7/c7edaedb-95b2- 438f-adfb-36de54f87b9e.pdf (October 20 2014).
  • Muhm JM, Rock PB, McMullin DL, Jones SP, Eilers KD, Space DR, et al. Effect of aircraft-cabin altitude on passenger discomfort. N Engl J Med 2007; 357: 18-27.
  • Tuncay E, Okatan EN, Vassort G, Turan B. ss-Blocker Timolol Prevents Arrhythmogenic Ca2+ Release and Normalizes Ca2+ and Zn2+Dyshomeostasis in Hyperglycemic Rat Heart. PLoS ONE 2013; 8: e71014.
  • Gururaja MP. Antidiabetic potential of cow urine in streptozotocin induced diabetic rats. Asian J Traditional Medicin 2011; 6: 8-13.
  • Dulak J, Józkowicz A, Dembinska-Kiec A, Guevara I, Zdzienicka A, Zmudzinska-Grochot D, et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20: 659-66.
  • Wolf G, Schroeder R, Stahl RA. Angiotensin II induces hypoxia- inducible factor-1 alpha in PC 12 cells through a posttranscriptional mechanism: role of AT2 receptors. Am J Nephrol 2004; 24: 415-21.
  • Available from: http://imagej.nih.gov/ij/ (October 20 2014).
  • Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001; 50: 536-46.
  • Powell FL, Garcia N. Physiological effects of intermittent hypoxia. High Alt Med Biol 2000; 12: 125-36.
  • Pilar Valle M, Garcia-Godos F, Woolcott O. Improvement of myocar- dial perfusion in coronary patients after intermittent hypobaric hypoxia. J Nucl Card 2006; 13: 69-74.
  • Zhong N, Zhang Y, Zhu HF, Wang JC, Fang QZ, Zhou ZN. Myocardial capillary angiogenesis and coronary flow in ischemia tolerance rat by adaptation to intermittent high altitude hypoxia. Acta Pharmacol Sin 2002; 23: 305-10.
  • Faeh D, Gutzwiller F, Bopp M; Swiss National Cohort Study Group. Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation 2009; 120: 495-501.
  • Zubiate M. Diabetes mellitus and high altitude. Diabetologia Croatica 2001; 30: 23-8.
  • Rubler S, Dlugash J, Yüceoğlu YZ, Kumral T, Branwood AW, Grishman A.New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972; 30: 595-602.
  • Hoit BD, Castro C, Bultron G, Knight S, Matlib MA. Noninvasive evaluation of cardiac dysfunction by echocardiography in strepto- zotocin-induced diabetic rats. J Card Fail 1999; 5: 324-33.
  • Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, Dillmann WH. Overexpression of the sarcoplasmic reticulum Ca+2-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 2002; 51: 1166-71.
  • Thompson EW. Quantitative analysis of myocardial structure in insulin-dependent diabetes mellitus: effects of immediate and delayed insulin replacement. Proc Soc Exp Biol Med 1994; 205: 294- 305.
  • Han B, Baliga R, Huang H, Giannone JP, Bauer JA. Decreased car- diac expression of vascular endothelial growth factor and redox imbalance in murine diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2009; 297: H829-35.
  • Sasso FC, Torella D, Carbonara O, Ellison GM, Torella M, Scardone M, et al. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium if type 2 diabetic patients with chronic coronary heart disease. J Am Coll Cardiol 2005; 46: 827-34.
  • Broderick TL, Parrott CR, Wang D, Jankowski M, Gutkowska J. Expression of cardiac GATA4 and downstream genes after exer- cise training in the db/db mouse. Pathophysiology 2012; 19: 193- 203.
  • Rivela R, Silvennoinen M, Touvra AM, Lehti TM, Kainulainen H, Vihko V. Effects of experimental type 1 diabetes and exercise train- ing on angiogenic gene expression and capillarization in skeletal muscle. FASEB Journal 2006; 20: E921-30.
  • Wang Z, Si LY. Hypoxia-inducible factor-1? and vascular endothe- lial growth factor in the cardioprotective effects of intermittent hypoxia in rats. Ups J Med Sci 2013; 118: 65-74.
  • Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia inducible factor 1. Mol Cell Biol 1996; 16: 4604-13.
  • Pugh WC, Ratcllile PC. Regulation of angiogenesis by hypoxia: Role of HIF system. Nat Med 2003; 9: 677-84.
  • Xue W, Cai L, Tan Y, Thistlethwaite P, Kang YJ, Li X, et al. Cardiac- Specific Overexpression of HIF-1? Prevents Deterioration of Glycolytic Pathway and Cardiac Remodeling in Streptozotocin- Induced Diabetic Mice. Am J Pathol 2010; 177: 97-105.
  • Milano G, Abruzzo PM, Bolotta A, Marini M, Terraneo L, Ravara B, et al. Impact of the phosphatidylinositide 3-kinase signaling path- way on the cardioprotection induced by intermittent hypoxia. PLoS One 2013; 8: e76659.
  • Rakusan K, Chvojkova Z, Oliviero P, Ostadalova I, Kolar F, Chassagne C, et al. ANG II type 1 receptor antagonist irbesartan inhibits coro- nary angiogenesis stimulated by chronic intermittent hypoxia in neonatal rats. Am J Physiol Heart Circ Physiol 2007; 292: H1237-44.
APA GÜZEL ERDOĞAN D, DURSUN A, FIÇICILAR H, Tekin D, TANYELİ A, AKAT F, ÇELİKKAN TOPAL F, SABUNCUOĞLU B, BASTUG M (2016). Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus. , 76 - 83.
Chicago GÜZEL ERDOĞAN DERYA,DURSUN ALİ DOĞAN,FIÇICILAR HAKAN,Tekin Demet,TANYELİ Ayhan,AKAT Fırat,ÇELİKKAN TOPAL Ferda,SABUNCUOĞLU Bizden,BASTUG METIN Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus. (2016): 76 - 83.
MLA GÜZEL ERDOĞAN DERYA,DURSUN ALİ DOĞAN,FIÇICILAR HAKAN,Tekin Demet,TANYELİ Ayhan,AKAT Fırat,ÇELİKKAN TOPAL Ferda,SABUNCUOĞLU Bizden,BASTUG METIN Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus. , 2016, ss.76 - 83.
AMA GÜZEL ERDOĞAN D,DURSUN A,FIÇICILAR H,Tekin D,TANYELİ A,AKAT F,ÇELİKKAN TOPAL F,SABUNCUOĞLU B,BASTUG M Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus. . 2016; 76 - 83.
Vancouver GÜZEL ERDOĞAN D,DURSUN A,FIÇICILAR H,Tekin D,TANYELİ A,AKAT F,ÇELİKKAN TOPAL F,SABUNCUOĞLU B,BASTUG M Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus. . 2016; 76 - 83.
IEEE GÜZEL ERDOĞAN D,DURSUN A,FIÇICILAR H,Tekin D,TANYELİ A,AKAT F,ÇELİKKAN TOPAL F,SABUNCUOĞLU B,BASTUG M "Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus." , ss.76 - 83, 2016.
ISNAD GÜZEL ERDOĞAN, DERYA vd. "Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus". (2016), 76-83.
APA GÜZEL ERDOĞAN D, DURSUN A, FIÇICILAR H, Tekin D, TANYELİ A, AKAT F, ÇELİKKAN TOPAL F, SABUNCUOĞLU B, BASTUG M (2016). Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus. The Anatolian Journal of Cardiology, 16(2), 76 - 83.
Chicago GÜZEL ERDOĞAN DERYA,DURSUN ALİ DOĞAN,FIÇICILAR HAKAN,Tekin Demet,TANYELİ Ayhan,AKAT Fırat,ÇELİKKAN TOPAL Ferda,SABUNCUOĞLU Bizden,BASTUG METIN Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus. The Anatolian Journal of Cardiology 16, no.2 (2016): 76 - 83.
MLA GÜZEL ERDOĞAN DERYA,DURSUN ALİ DOĞAN,FIÇICILAR HAKAN,Tekin Demet,TANYELİ Ayhan,AKAT Fırat,ÇELİKKAN TOPAL Ferda,SABUNCUOĞLU Bizden,BASTUG METIN Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus. The Anatolian Journal of Cardiology, vol.16, no.2, 2016, ss.76 - 83.
AMA GÜZEL ERDOĞAN D,DURSUN A,FIÇICILAR H,Tekin D,TANYELİ A,AKAT F,ÇELİKKAN TOPAL F,SABUNCUOĞLU B,BASTUG M Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus. The Anatolian Journal of Cardiology. 2016; 16(2): 76 - 83.
Vancouver GÜZEL ERDOĞAN D,DURSUN A,FIÇICILAR H,Tekin D,TANYELİ A,AKAT F,ÇELİKKAN TOPAL F,SABUNCUOĞLU B,BASTUG M Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus. The Anatolian Journal of Cardiology. 2016; 16(2): 76 - 83.
IEEE GÜZEL ERDOĞAN D,DURSUN A,FIÇICILAR H,Tekin D,TANYELİ A,AKAT F,ÇELİKKAN TOPAL F,SABUNCUOĞLU B,BASTUG M "Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus." The Anatolian Journal of Cardiology, 16, ss.76 - 83, 2016.
ISNAD GÜZEL ERDOĞAN, DERYA vd. "Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus". The Anatolian Journal of Cardiology 16/2 (2016), 76-83.